Search results
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to...
Valley City Times Record· 2 days ago- Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
AbbVie shares hold Buy rating with $180 target from TD Cowen By Investing.com
Investing.com· 20 hours agoOn Tuesday, TD (TSX:TD) Cowen maintained a positive stance on AbbVie Inc . TD Cowen adjusted its...
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 3 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering ...
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 6 days agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
Barrons.com· 7 days agoShares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 6 days agoFurther, Karuna Therapeutics and Cerevel Therapeutics have shown promise with this mechanism....
Ajax, aiming for a better JAK drug, raises $95M to begin first tests
BioPharma Dive via Yahoo Finance· 2 days agoGoldman Sachs and Eli Lilly are among those backing the startup, which claims its prospect could be...
Halozyme to Participate in Upcoming Investor Conferences
NBC 10 - FOX 14 Monroe· 7 days agoA live audio webcast of the JMP presentation will be available on the Investor Relations section of the Company's website. Replays of the audio webcasts will be available for 90 days following the conference.
Vibegron Is Effective for Overactive Bladder in Men With BPH
Medscape· 6 days agoTreatment of overactive bladder can be more complex in the context of benign prostatic hyperplasia,...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoNEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: RBC Capital Markets 2024 Global Healthcare Conference
